![]() |
Product Name | MLN8237 |
Product Page | Visit the Product |
Product Description | MLN8237 is a second-generation, orally bioavailable, highly selective small molecule inhibitor of the Aurora A kinase (serine/threonine protein kinase) with potential antineoplastic activity. [1] MLN8237 binds to and inhibits Aurora A kinase, which may result in disruption of the assembly of the mitotic spindle apparatus, disruption of chromosome segregation, and inhibition of cell proliferation. [1] After treatment in eight multiple myeloma cell lines with MLN8237 (0.0001 ¦ÌM ¨C 4 ¦ÌM) for 48 h, the affect of Aurora A kinase inhibition and a marked effect on both viability and proliferation (0.01 ¦ÌM) was examined. Tumor burden was significantly reduced and overall survival was significantly increased in animals treated with 30mg/kg MLN8237. |
Product Manual | Read Product Manual |
Price | $150 |
Specification | 5mg |
Product Review | 0
![]() |
Vendor Information |
Selleck
http://www.selleckchem.com/ 2626 South Loop West, Suite 225, Houston, TX 77054 USA TX USA |